anonymous
Guest
anonymous
Guest
Attention new hires! You will also be one of the lowest salaried representatives in the industry. Don't beleive me? Check out the starting salary at other pharma companies. Also, look at the number of positions open across the nation, they are open because there is no future at KPA. Kowa has decreased its field force from 311 reps to approximately 240+ reps, mostly by forcing reps out, so they do not have to pay severence pay. Livalo goes generic in November and they have nothing to replace it. Don't beleive me? Look at there pipeline of drugs, the closest one is at least two years away from approval, if it gets approved. Seglentis is not what they claim it is, its been a over a year now since the launch, and look at the sales, numbers don't lie. Leadership is terrible! No co-promote in sight, Warning, do not come here.